FEDERATED HERMES, INC. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$11,321
+52.6%
1,064
+50.9%
0.00%
Q1 2023$7,417
-13.6%
705
+1.7%
0.00%
Q4 2022$8,586
-57.1%
693
-64.8%
0.00%
Q3 2022$20,000
-45.9%
1,967
-37.9%
0.00%
Q2 2022$37,000
-97.7%
3,166
-97.6%
0.00%
-100.0%
Q1 2022$1,639,000
-71.9%
130,250
-74.0%
0.00%
-63.6%
Q4 2021$5,840,000
-10.6%
500,819
+0.1%
0.01%
-8.3%
Q3 2021$6,533,000
+5.6%
500,200
+4.0%
0.01%0.0%
Q2 2021$6,188,000
+13.6%
480,775
-1.4%
0.01%
+9.1%
Q1 2021$5,449,000
-4.9%
487,388
-3.1%
0.01%
-8.3%
Q4 2020$5,727,000
+27.0%
502,747
+0.3%
0.01%
+9.1%
Q3 2020$4,510,000
-25.8%
501,341
-14.8%
0.01%
-26.7%
Q2 2020$6,076,000
+3.4%
588,717
+1.1%
0.02%
-11.8%
Q1 2020$5,874,000
-12.7%
582,170
+15.1%
0.02%
+13.3%
Q4 2019$6,731,000
+227.5%
505,685
+354.3%
0.02%
+200.0%
Q3 2018$2,055,000
+244.8%
111,310
+218.5%
0.01%
+150.0%
Q1 2017$596,00034,9510.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$188,977,00019.02%
13D Management LLC 600,431$6,923,0003.06%
BRIDGER MANAGEMENT, LLC 956,014$11,023,0002.48%
Brown Capital Management 11,641,935$134,232,0001.80%
Price Jennifer C. 520,000$5,996,0001.02%
Monarch Partners Asset Management LLC 272,425$3,141,0000.88%
ALPHASIMPLEX GROUP, LLC 10,510$121,0000.86%
Intrinsic Value Partners, LLC 54,105$624,0000.80%
CLARK ESTATES INC/NY 355,000$4,093,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 692$60,000,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders